Publications by authors named "Tomas Rees"

Claim this Profile
D
Does the impact of medical publications vary by disease indication and publication type? An exploration using a novel, value-based, publication metric framework: the EMPIRE Index.
Tomas Rees, Avishek Pal

F1000Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the impact of scientific publications and publication extenders: examples of novel approaches.
Avishek Pal, Wesley Portegies, Jennifer Schwinn, Michael Taylor, Tomas J Rees

Curr Med Res Opin· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introducing the EMPIRE Index: A novel, value-based metric framework to measure the impact of medical publications.
Avishek Pal, Tomas James Rees

PLoS One· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying and Validating Networks of Oncology Biomarkers Mined From the Scientific Literature.
Kim Wager, Dheepa Chari, Steffan Ho, Tomas Rees, Orion Penner

Cancer Inform· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress and controversies: treating obesity and insulin resistance in the context of hypertension.
Janet B McGill, Steven Haffner, Tomas J Rees, James R Sowers, Andrew M Tershakovec

J Clin Hypertens (Greenwich)· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal management of lipids in diabetes and metabolic syndrome.
W Virgil Brown, Luther Clark, James M Falko, John R Guyton, Tomas J Rees

J Clin Lipidol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular high-risk patients--treat to protect, but whom?
Faiez Zannad, Anne Jakobsen, Jose Heroys, Ann Ralph, Tomas Rees

Medscape J Med· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No HOPE without proof: do ARBs meet the standard for cardiovascular protection?
Peter Sleight, Anne Jakobsen, Jose Heroys, Ann Ralph, Tomas Rees

Medscape J Med· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac and vascular protection: the potential of ONTARGET.
Giuseppe Mancia, Anne Jakobsen, Jose Heroys, Ann Ralph, Tomas Rees

Medscape J Med· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cardiovascular protection: the concept of dual renin-angiotensin system control.
Thomas Unger, Anne Jakobsen, Jose Heroys, Ann Ralph, Tomas Rees

Medscape J Med· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospects for renovascular protection by more aggressive renin-angiotensin system control.
Luis Miguel Ruilope, Anne Jakobsen, Jose Heroys, Ann Ralph, Tomas Rees

Medscape J Med· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new dawn in cardio and vascular protection v. cardiovascular high-risk patients: treat to protect.
Toshiro Fujita, Giuseppe Mancia, Anne Jakobsen, Jose Heroys, Ann Ralph, Tomas Rees

Medscape J Med· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating to protect: current cardiovascular treatment approaches and remaining needs.
Michael Böhm, Christian Werner, Anne Jakobsen, Jose Heroys, Ann Ralph, Tomas Rees

Medscape J Med· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis